← Back to Search

CLASP-PE arm for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Ronald Acierno, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post treatment
Awards & highlights

Study Summary

This trial is testing a new intervention to prevent blood clots and PE (pulmonary embolism). They hope it is safe, accepted, feasible, and efficacious.

Who is the study for?
This trial is for active duty service members who have PTSD, confirmed by the CAPS scale, and are experiencing suicidal thoughts or have attempted suicide. Participants must be able to communicate in English to consent and complete study tasks. Those with current psychotic/manic episodes, severe substance use disorder, or undergoing certain other PTSD/suicide-focused therapies cannot join.Check my eligibility
What is being tested?
The CLASP-PE arm intervention is being tested for its safety, acceptability, feasibility, and efficacy in reducing PTSD-related distress and suicidal behaviors/thoughts among military personnel. This pilot study aims to gather initial data on the effectiveness of this integrated approach.See study design
What are the potential side effects?
Since this trial involves a psychological intervention rather than medication, traditional side effects like those seen with drugs may not apply. However, participants might experience emotional discomfort or increased distress as they confront traumatic memories during therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Extent to which client was satisfied with the training as assessed by the Client Satisfaction Questionnaire (CSQ)
Feedback form participants as assessed by the Qualitative interview(QI) which will include a series of open ended questions aimed at eliciting feedback from participants about their perspective on the PE-CLASP Intervention
Intensity of attitudes, behaviors and plans to commit suicide over the prior week as assessed by the Beck Scale for Suicidal ideation(BSSI)
+6 more
Secondary outcome measures
Number of potentially traumatic events in a respondent's lifetime as assessed by The Life Events Checklist for DSM-5 (LEC-5).

Trial Design

1Treatment groups
Experimental Treatment
Group I: CLASP-PE armExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
909 Previous Clinical Trials
323,741 Total Patients Enrolled
Ronald Acierno, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
2 Previous Clinical Trials
326 Total Patients Enrolled

Media Library

CLASP-PE Clinical Trial Eligibility Overview. Trial Name: NCT04284410 — N/A
Post-Traumatic Stress Disorder Research Study Groups: CLASP-PE arm
Post-Traumatic Stress Disorder Clinical Trial 2023: CLASP-PE Highlights & Side Effects. Trial Name: NCT04284410 — N/A
CLASP-PE 2023 Treatment Timeline for Medical Study. Trial Name: NCT04284410 — N/A
Post-Traumatic Stress Disorder Patient Testimony for trial: Trial Name: NCT04284410 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to participate in this experiment currently?

"Affirmative. The trial listing on clinicaltrials.gov states that the study, which was initially posted in October 2021, is presently searching for participants to join their research team. 15 individuals are necessary from a single site for this investigation."

Answered by AI

How many people are being administered the treatment in this experimental trial?

"Affirmative. Clinicaltrials.gov records indicate that this medical trial is currently receiving applications, which began on October 2nd 2021 and was last updated on the 31st of October 2022. The study requires 15 individuals at a single site to contribute data."

Answered by AI

Who else is applying?

What state do they live in?
Louisiana
Texas
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+
What site did they apply to?
The University of Texas Health Science Center at Houston

Why did patients apply to this trial?

I am on a seemingly endless downward spiral with less and less hope for my existence.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Integration of PE & Coping Long-Term With Active Suicide Program for PTSD & Suicide Risk in Military Families
Ronald E. Acierno 2021. "Integration of PE & Coping Long-Term With Active Suicide Program for PTSD & Suicide Risk in Military Families". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04284410.
~0 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top